Clinical Research Directory
Browse clinical research sites, groups, and studies.
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Sponsor: Nadine McCleary, MD, MPH
Summary
SURGE aims to increase equity in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of the intervention. The intervention is comprised of a patient navigator, text message questionnaire, and informational video.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2023-04-03
Completion Date
2028-07-30
Last Updated
2025-11-05
Healthy Volunteers
No
Interventions
SURGE
Video with or without person to person guidance to support decision making around genetic testing
Locations (3)
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
Brighton, Massachusetts, United States
Dana-Farber Cancer Instiute - Merrimack Valley
Methuen, Massachusetts, United States